Natural History Study of Patients With Canavan Disease (CANinform Study)

Plain-language summary

This study observes the natural course of Canavan disease, an inherited condition, over time. It enrolled patients with a confirmed clinical and biochemical diagnosis of Canavan disease who had medical records available since birth. The study was a non-phased observational study and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Completed

Sponsor

Aspa Therapeutics

Start date

10/10/2019

Estimated completion

8/31/2025

Countries

United States, Germany

Related genes

Locations

• Oakland, United States
• Boston, United States
• Hamburg, Germany

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

1. Meet age criteria of a specific cohort.
2. Confirmed clinical and biochemical diagnosis of Canavan disease.
3. Available medical records since birth that permit documentation of disease characteristics and developmental milestones.
4. Parent and/or legal guardian is able to read, understand, and sign the informed consent.

Exclusion Criteria:

1\. Patient does not meet the Inclusion Criteria.